Tumor growth speed and head and neck cancer treatment outcome
Part of Cancer clinical trials.
This study looks at whether the speed at which your head and neck cancer grows (called tumor growth velocity) can help predict how well your treatment will work. If you are already scheduled for radiation or chemo-radiation, your doctors will review your CT scans to see if this growth measure is useful for planning care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of head and neck cancer called squamous cell carcinoma (stages T1 to T4) in your mouth, throat, voice box, or lower throat.
- Your doctor has decided that you will receive radiation therapy, either alone or combined with chemotherapy.
- The cancer has not spread to other parts of your body (no distant metastasis).
- You are not planning to have surgery as the first treatment.
- You can safely receive the iodine-based contrast dye used for CT scans — meaning no serious allergies to it and no kidney problems that would prevent its use.
- The tumor is visible on a CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a PET/CT scan (a special scan that can look for signs of cancer activity) after curative treatment for head and neck squamous cell cancer. It aims to help check how well prior treatment is working and whether cancer may come back.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial tests if monitoring cancer DNA left in your blood after surgery can help decide if you need additional treatment. It is for people with HPV-positive oropharynx (throat) cancer who have a certain amount of cancer DNA detected before surgery.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This trial tests a safer radiation plan that may reduce dose to the opposite (other) side of the neck while still treating the cancer spread risk. It uses special mapping to guide treatment and looks at patients whose cancer is already in an involved lymph node on one side.
This study looks at how outcomes may be predicted for people with head and neck cancer who receive radiotherapy. It may help doctors better estimate results and tailor follow-up care.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.